Once-daily solifenacin succinate or extended-release tolterodine for overactive bladder syndrome?

被引：0
|
作者：
Wyndaele, JJ [1 ]
机构：
[1] Univ Antwerp, Dept Urol, Edegem, Belgium
来源：
NATURE CLINICAL PRACTICE UROLOGY | 2006年 / 3卷 / 04期
关键词：
antimuscarinic; overactive bladder syndrome; solifenacin succinate; tolterodine;
D O I：
10.1038/ncpuro0440
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [21] A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women
    Peter K. Sand
    John Miklos
    Henry Ritter
    Rodney Appell
    [J]. International Urogynecology Journal, 2004, 15 : 243 - 248
  • [22] A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women
    Sand, PK
    Miklos, J
    Ritter, H
    Appell, R
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2004, 15 (04) : 243 - 248
  • [23] ONCE-DAILY, EXTENDED-RELEASE GEMFIBROZIL IN PATIENTS WITH DYSLIPIDEMIA
    GOTTO, AM
    BREEN, WJ
    CORDER, CN
    DUNN, JK
    GOLDBERG, A
    KNOPP, RH
    SCHROTT, H
    SPRECHER, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (12): : 1057 - 1063
  • [24] Pharmacokinetic profile of once-daily cyclobenzaprine extended-release
    Darwish, Mona
    Hellriegel, Edward T.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1425 - 1436
  • [25] Once-Daily Trospium Chloride 60 mg Extended-Release Provides Effective, Long-Term Relief of Overactive Bladder Syndrome Symptoms
    Zinner, Norman R.
    Dmochowski, Roger R.
    Staskin, David R.
    Siami, Paul F.
    Sand, Peter K.
    Oefelein, Michael G.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) : 1214 - 1219
  • [26] Once-daily extended-release liquid for ADHD approved
    不详
    [J]. NURSE PRACTITIONER, 2018, 43 (01): : 56 - 56
  • [27] Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia
    Nitti, Victor W.
    Dmochowski, Roger
    Appell, Rodney A.
    Wang, Joseph T.
    Bavendam, Tamara
    Guan, Zhonghong
    [J]. BJU INTERNATIONAL, 2006, 97 (06) : 1262 - 1266
  • [28] Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder
    Ginsberg, David
    Schneider, Tim
    Kelleher, Con
    Van Kerrebroeck, Philip
    Swift, Steven
    Creanga, Dana
    Martire, Diane L.
    [J]. BJU INTERNATIONAL, 2013, 112 (03) : 373 - 385
  • [29] Treatment of overactive bladder: A model comparing extended-release formulations of tolterodine and oxybutynin
    Perfetto, EM
    Subedi, P
    Jumadilova, Z
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (04): : S150 - S157
  • [30] Development and Optimization of Once-Daily Extended-Release Formulations of Topiramate
    Lambrecht, Lawrence J.
    Todd, Wesley M.
    Halvorsen, Mark B.
    [J]. NEUROLOGY, 2011, 76 (09) : A50 - A50
12345